AHA Scientific Sessions 2022 Program, Late Breakers Announced

The American Heart Association (AHA) Scientific Sessions 2022 in Chicago, and virtually, is set for November 5-7 at McCormick Place. Highly-anticipated clinical trial breakthroughs and discoveries of the year will be offered in both late-breaking scientific sessions and featured science sessions.

Related Keywords

China ,Boston ,Massachusetts ,United States ,Mccormick Place ,Illinois ,Chicago ,Chinese ,American ,Nancy Brown ,Juanf Granada ,American Heart Association ,Office Blood Pressure ,Electronic Health Record ,Cardiovascular Research Foundation ,Scientific Sessions ,Pre Session Symposia ,Early Career Day ,Special Lectures ,Council Awards ,Named Lectures ,Distinguished Achievement ,Best Abstract ,Early Career Abstract ,Heart Theater ,Learning Studios ,Puppy Snuggle Zone ,Breaking Scientific Session ,Main Event ,Changing Clinical Practice ,Comparative Effectiveness ,Heart Failure ,Primary Results ,Chlorthalidone Compared ,Cardiovascular Events ,Randomized Trial ,Triglyceride Reduction ,Ttr Gene ,Transthyretin Amyloidosis With ,Patient Risk Based Health System Intervention ,Acute Heart Failure Care ,Yearly Results ,Patient Reported Outcome Measurement ,Heart Failure Clinic ,Intravenous Ferric Derisomaltose ,Reduced Ejection ,Impact Trials ,Radial Artery Patency ,Clinical Outcomes ,Randomized Trials ,Year Clinical Outcomes Comparing Radial Artery ,Right Internal Thoracic Artery ,With Saphenous Vein ,Chinese Herbal Medicine ,Acute Myocardial Infarction ,Results From ,Extracorporeal Membrane Oxygenation ,Cardiogenic Shock ,Chronic Hypertension Management ,Cardiovascular Disease Among Patients ,Cluster Randomized ,Life Project ,Reducing Inequities ,Lifestyle Improvement ,Blood Pressure ,Adapted Mindfulness Training ,Elevated Office Blood Pressure ,Mindfulness Based Blood Pressure Reduction ,Randomized Clinical ,Quadruple Ultra Low Dose Treatment ,Randomized Controlled ,Prevent Cardiovascular ,Renal Disease ,Evaluating Secondary Prevention Efficacy ,Combination Therapy ,With Small Interfering ,Cardiovascular Outcomes ,Chronic Kidney Disease ,Low Dose Statin Compared ,Six Dietary Supplements ,Inflammatory Biomarkers ,Bivalirudin With ,Dose Infusion ,Precision Care Strategy ,Usual Testing ,Guide Management ,Precise Randomized ,Follow Up Interim ,Limb Loss Through Vascular Interventions ,Venous Therapies ,Best Endovascular ,Best Surgical Therapy ,Chronic Limb Threatening Ischemia ,Major Venous ,Arterial Thrombotic Events ,Medically Ill Outpatients ,Multicenter Clustered Randomized Trial ,Integrated Clinical Decision Support ,Hospitalized Medically Ill ,Supraventricular Arrhythmias ,Atrial Fibrillation Progression ,Self Administered Etripamil ,Primary Analysis ,Botulinum Toxin Type ,Postoperative Atrial Fibrillation ,Cardiac Surgery Patients ,Clinical Trial ,Pressure Cooker ,Top Line Results ,Treatment Resistant Hypertension ,Sustained Blood Pressure Lowering Effect ,Dual Endothelin Receptor Antagonist Aprocitentan ,Resistant Hypertension ,Controlled Study Including ,Placebo Controlled Trial Evaluating ,Radiofrequency Renal Denervation ,Antihypertensive Drugs ,Month Primary Results ,Fresh Look ,Heart Rhythm ,Best Practices ,Executive Officer ,Chief Executive Officer ,